AR023185A1 - Tratamiento de cancer mejorado con temozolomida - Google Patents

Tratamiento de cancer mejorado con temozolomida

Info

Publication number
AR023185A1
AR023185A1 ARP000101370A ARP000101370A AR023185A1 AR 023185 A1 AR023185 A1 AR 023185A1 AR P000101370 A ARP000101370 A AR P000101370A AR P000101370 A ARP000101370 A AR P000101370A AR 023185 A1 AR023185 A1 AR 023185A1
Authority
AR
Argentina
Prior art keywords
temozolomide
days
cycle
cancer treatment
during
Prior art date
Application number
ARP000101370A
Other languages
English (en)
Spanish (es)
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of AR023185A1 publication Critical patent/AR023185A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ARP000101370A 1999-03-30 2000-03-27 Tratamiento de cancer mejorado con temozolomida AR023185A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US28134899A 1999-03-30 1999-03-30

Publications (1)

Publication Number Publication Date
AR023185A1 true AR023185A1 (es) 2002-09-04

Family

ID=23076905

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000101370A AR023185A1 (es) 1999-03-30 2000-03-27 Tratamiento de cancer mejorado con temozolomida

Country Status (18)

Country Link
EP (1) EP1165071B1 (enExample)
JP (2) JP2002540148A (enExample)
CN (2) CN102160864A (enExample)
AR (1) AR023185A1 (enExample)
AT (1) ATE310515T1 (enExample)
AU (1) AU780892B2 (enExample)
BR (1) BR0009380A (enExample)
CA (1) CA2368614C (enExample)
DE (1) DE60024243T2 (enExample)
DK (1) DK1165071T3 (enExample)
ES (1) ES2251987T3 (enExample)
HK (1) HK1044111B (enExample)
HU (1) HUP0200805A3 (enExample)
NO (1) NO330651B1 (enExample)
NZ (1) NZ536302A (enExample)
TW (1) TWI276434B (enExample)
WO (1) WO2000057867A2 (enExample)
ZA (1) ZA200107736B (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100366249C (zh) * 2002-09-29 2008-02-06 天津帝士力投资控股集团有限公司 一种替莫唑胺控释给药系统
CN1742723A (zh) * 2004-09-02 2006-03-08 天津倍方科技发展有限公司 含有替莫唑胺－8－羧酸酯的药物组合物以及该类化合物用于制备抗肿瘤药物的用途
CN1299772C (zh) * 2004-10-14 2007-02-14 孔庆忠 一种抗癌药物组合物
US20060100188A1 (en) * 2004-11-09 2006-05-11 Chen Zong Treatment methods
SI2338487T1 (sl) * 2006-01-17 2014-01-31 Abbott Laboratories Kombinacijska terapija z inhibitorji PARP
CA2648640C (en) * 2006-04-05 2016-02-16 Schering Corporation Pharmaceutical formulations: salts of 8-[{1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one and treatment methods using the same
AR061618A1 (es) * 2006-06-26 2008-09-10 Schering Corp Formas de dosificacion unitaria de temozolomida
WO2008022535A1 (fr) * 2006-08-09 2008-02-28 Tian Jin Tasly Group Co., Ltd. Composition pharmaceutique pour traiter le gliome du cerveau, son procédé et sa préparation pharmaceutique
NZ575636A (en) * 2006-09-29 2012-02-24 Cipla Ltd An improved process for the preparation of temozolomide and analogs
JP6112512B2 (ja) * 2010-12-01 2017-04-12 レクシ ファーマ インコーポレイテッド 難治性癌を治療するための方法
CN102526038B (zh) * 2011-01-12 2013-09-11 北京人福军威医药技术开发有限公司 替莫唑胺的脑靶向药物组合物及其应用
CN107397735B (zh) * 2017-07-28 2020-07-10 东曜药业有限公司 一种替莫唑胺药物组合物及其制备方法和应用
CN117338750A (zh) * 2023-11-24 2024-01-05 郑州德迈药业有限公司 一种替莫唑胺制剂及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69625373T2 (de) * 1995-10-04 2003-05-15 Schering Corp., Kenilworth Kombination von temozolomide und alpha-interferon zur behandlung von fortgeschrittenem krebs
CA2184546A1 (en) * 1996-07-31 1998-02-01 Margaret H. Dugan Method for treating pediatric high grade astrocytoma including brain stem glioma
CA2184545A1 (en) * 1996-07-31 1998-02-01 Pascale Reidenberg Cancer treatment with temozolomide

Also Published As

Publication number Publication date
NO20014725L (no) 2001-11-13
DK1165071T3 (da) 2006-02-20
BR0009380A (pt) 2001-12-26
NO330651B1 (no) 2011-05-30
NO20014725D0 (no) 2001-09-28
ZA200107736B (en) 2003-02-26
CA2368614C (en) 2008-07-22
HUP0200805A3 (en) 2004-07-28
CN1345240A (zh) 2002-04-17
JP2002540148A (ja) 2002-11-26
HK1044111B (en) 2006-02-24
EP1165071A2 (en) 2002-01-02
HUP0200805A2 (hu) 2002-07-29
HK1044111A1 (en) 2002-10-11
TWI276434B (en) 2007-03-21
EP1165071B1 (en) 2005-11-23
DE60024243T2 (de) 2006-08-17
NZ536302A (en) 2006-05-26
CN102160864A (zh) 2011-08-24
WO2000057867A2 (en) 2000-10-05
WO2000057867A3 (en) 2001-04-19
AU780892B2 (en) 2005-04-21
ATE310515T1 (de) 2005-12-15
DE60024243D1 (de) 2005-12-29
JP2007169297A (ja) 2007-07-05
AU3924400A (en) 2000-10-16
ES2251987T3 (es) 2006-05-16
CA2368614A1 (en) 2000-10-05

Similar Documents

Publication Publication Date Title
NO20014519L (no) Apomorfin- og sildenafilpreparat
ES2603086T3 (es) Uso de la daptomicina
CY1111088T1 (el) Θεραπευτικη φαρμακοτεχνικη μορφη για χορηγηση τολτεροδινης με ελεγχομενη απελευθερωση
RU2012106620A (ru) Комбинации и способы введения терапевтических средств и комбинированной терапии
MX9203443A (es) Una forma de dosis para el suministro retardado de un farmaco.
NZ517038A (en) Use of serotonin reuptake inihibitor in medicaments for treating sexual dysfunction
MXPA05012810A (es) Formas de dosis oral de memantina.
WO2000057867A3 (en) Improved cancer treatment with temozolomide
ATE405272T1 (de) Behandlung von t-zellen-lymphom mittels 10- propargyl-10-deazaaminopterin
JP2002540148A5 (enExample)
MD1875F1 (en) Method of treatment of the acute viral hepatitis B
CA2435921A1 (en) Method of cancer therapy
EA200400591A1 (ru) СПОСОБ ВВЕДЕНИЯ ПЕПТИДА ТИМОЗИН α1
AR029160A1 (es) El uso del interferon-alfa pegilado para la preparacion de un medicamento para el tratamiento del carcinoma de celula renal, un kit y el uso del mismo
EA200800075A1 (ru) Схема дозирования для празугреля
RU2002129298A (ru) Применение галантамина для лечения психоневрологического поведения, связанного с болезнью альцгеймера
ATE298240T1 (de) Getrennte dosis therapien mit gefässschädigender aktivität
AR047154A1 (es) Tratamiento del insomnio en pacientes humanos administrandoles una cantidad diaria de gaboxadol
EA199800770A1 (ru) Лекарственный препарат для терапевтического лечения вирусного гепатита
RU2001102089A (ru) Способ лечения дисциркуляторной энцефалопатии
CO5170404A1 (es) Terapia para melanomas
RU94006790A (ru) Способ лечения больных хроническими неспецифическими заболеваниями легких
UA30251A (uk) Спосіб лікування гіпертонії сфінктера одді у хворих на хронічний безкам'яний холецистит при поєднанні з підвищенням тонусу симпатичної нервової системи
RU2007141134A (ru) Лечение дронабинолом индуцированной химиотерапией тошноты и рвоты замедленного типа
RU2001128509A (ru) Способ лечения нейродегенерации

Legal Events

Date Code Title Description
FB Suspension of granting procedure